ChristopherAndrewYasenchakMD

Summary

• I am a lymphoma specialist, clinical researcher, and immunotherapy leader committed to bridging academic research with real-world oncology care, particularly for elderly and infirm patients. As CAR-T/Bispecifics Medical Director at Willamette Valley Cancer Institute, I lead a multidisciplinary team managing complex lymphoma cases, ensuring the safe and effective integration of CAR-T and bispecific antibody therapies into community-based practice.
  
  A major focus of my work is improving treatment options for elderly and frail patients, who often face unique challenges in lymphoma care, including limited tolerance for intensive therapies. As a Principal Investigator within the US Oncology Research network, I lead clinical trials focused on novel therapies for Classical Hodgkin Lymphoma (CHL) and other lymphomas, with a specific emphasis on tailoring treatments for elderly and high-risk populations.
  
  Additionally, as a Lymphoma Executive Committee Member at the Sarah Cannon Research Institute, I collaborate with global experts to translate the latest research into practical, community-based applications—helping expand access to innovative treatments beyond major academic centers.
  
  Key areas of focus:
  • Leadership in CAR-T and bispecific antibody therapies in community settings
  • Principal investigator in clinical trials for elderly and infirm patients with lymphoma
  • Advancing novel therapies for Classical Hodgkin Lymphoma in high-risk populations
  • Multidisciplinary care and real-world application of immunotherapies
  • Bridging academic research with practical applications in community-based oncology
  
  Over the past decade, my research efforts have resulted in numerous peer-reviewed publications, conference presentations, and collaborations with leading lymphoma experts. I am committed to expanding access to novel, less toxic therapies for elderly patients who might not tolerate traditional treatments, ensuring that innovative breakthroughs reach those who need them